IRIS
TETI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.183
EU - Europa 3.914
AS - Asia 1.635
OC - Oceania 8
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.173
IE - Irlanda 1.171
CN - Cina 905
SE - Svezia 776
TR - Turchia 666
DE - Germania 459
UA - Ucraina 383
GB - Regno Unito 373
IT - Italia 350
FI - Finlandia 189
FR - Francia 133
BE - Belgio 26
IN - India 26
RU - Federazione Russa 21
VN - Vietnam 18
NL - Olanda 11
AU - Australia 6
CA - Canada 6
IL - Israele 6
JP - Giappone 5
BR - Brasile 4
EG - Egitto 3
ES - Italia 3
MX - Messico 3
BG - Bulgaria 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SG - Singapore 2
AL - Albania 1
AT - Austria 1
BN - Brunei Darussalam 1
HK - Hong Kong 1
HU - Ungheria 1
IM - Isola di Man 1
LU - Lussemburgo 1
MN - Mongolia 1
NO - Norvegia 1
PL - Polonia 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 11.749
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.497
Chandler 1.280
Dublin 1.168
Izmir 321
San Mateo 301
Boardman 288
Nanjing 280
Wilmington 277
Lawrence 201
Princeton 201
New York 198
Ann Arbor 137
Woodbridge 111
Ashburn 103
Milan 96
Nanchang 92
Seattle 86
Shenyang 86
L'aquila 69
Mountain View 67
Des Moines 65
Verona 60
Falls Church 57
Tianjin 56
Hebei 46
Bremen 43
Jiaxing 43
Beijing 42
Kunming 42
Dearborn 37
Ningbo 31
Changsha 27
Philadelphia 27
Jinan 26
Norwalk 25
Los Angeles 24
Brussels 20
Guangzhou 19
Dong Ket 18
Rome 18
Pune 16
Shanghai 16
Zhengzhou 16
Fremont 14
Helsinki 13
Lanzhou 13
Tappahannock 13
Houston 11
Taizhou 11
Aquila 8
Auburn Hills 8
Pescara 8
Strasbourg 8
Changchun 7
Düsseldorf 7
Fuzhou 7
Hangzhou 7
Fairfield 6
Redwood City 6
Washington 6
West Jordan 6
London 5
L’Aquila 5
Moscow 5
Redmond 5
Würzburg 5
Ghent 4
Hefei 4
Lappeenranta 4
Paris 4
Shangdi 4
Xian 4
Adelaide 3
Amsterdam 3
Edinburgh 3
Istanbul 3
Jinhua 3
Plymouth 3
Stockholm 3
Teramo 3
Toulouse 3
Athens 2
Baotou 2
Bayonne 2
Cairo 2
Cambridge 2
Ceglie Messapica 2
Centrale 2
Chicago 2
Frankfurt am Main 2
Grafing 2
Harbin 2
Menlo Park 2
Mexico City 2
Monserrato 2
Montreal 2
Nerviano 2
Orange 2
Paganica 2
Palagonia 2
Totale 7.906
Salva come PNG Salva come JPEG
Nome #
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 140
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis 105
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 102
CALCITONIN DOWN-REGULATES IMMEDIATE CELL SIGNALS INDUCED IN HUMAN OSTEOCLAST-LIKE CELLS BY THE BONE SIALOPROTEIN-IIA FRAGMENT THROUGH A POSTINTEGRIN RECEPTOR MECHANISM 94
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 92
Oligodeoxynucleotide targeted to the alpha(v) gene inhibits alpha(v) integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis 91
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy? 85
Osteoplastic activity of mature osteocytes evaluated by H-proline incorporation. 84
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 83
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro 82
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 81
Ultrastructural study of human adrenal pheochromocytoma by open needle biopsy. 79
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 78
Osteoclast isolation: New developments and methods 78
Bone metastasis: pathogenesis and therapeutic implications 77
Modulation of estrogen receptor levels in mouse uterus by protein kinase C isoenzymes 77
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 77
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 77
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 76
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 75
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood 75
Tyrosine kinase Src inhibitors: Potential therapeutic applications 75
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 75
OSTEOCLAST CYTOSOLIC CALCIUM, REGULATED BY VOLTAGE-GATED CALCIUM CHANNELS AND EXTRACELLULAR CALCIUM, CONTROLS PODOSOME ASSEMBLY AND BONE-RESORPTION 74
PLEKHM1 is involved in osteoclastic vesicular transport and mutations in this gene cause osteopetrosis in incisors absent rat and human 74
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 74
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 74
An antisense oligonucleotide targeting the alpha V integrin gene inhibits adhesion and induces apoptosis in breast cancer cells 73
The "love-hate" relationship between osteoclasts and bone matrix 73
Congenital disorders of bone and blood 73
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 72
Signaling in osteoblasts integrates bone remodeling and energy metabolism 72
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 72
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders 72
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 72
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 71
Protein kinase C modulates estrogen receptors in differentiated osteoblastic cells in vitro 71
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy 71
ROUS-SARCOMA VIRUS-TRANSFORMED FIBROBLASTS AND CELLS OF MONOCYTIC ORIGIN DISPLAY A PECULIAR DOT-LIKE ORGANIZATION OF CYTOSKELETAL PROTEINS INVOLVED IN MICROFILAMENT MEMBRANE INTERACTIONS 71
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 71
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 70
THE EFFECTS OF PARATHYROID-HORMONE OR 1,25-DIHYDROXYVITAMIN-D3 ON MONOCYTE-OSTEOCLAST FUSION 70
Association of intermediate osteopetrosis with poikiloderma 70
A six-gene signature predicting breast cancer lung metastasis 70
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 69
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 69
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 69
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 69
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 69
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 69
Osteoclast-poor human osteopetrosis due to mutations in RANKL 69
Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells 69
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 68
Interaction of estrogen receptor a with protein kinase C alpha and c-Src in osteoblasts during differentiation 68
Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro 68
The Great Beauty of the osteoclast 68
Non-conventional role of haemoglobin beta in breast malignancy 68
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 68
Influence of calcium depletion on medullary bone of laying hens. 67
Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology 67
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 67
Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. 66
NEW MODEL FOR BONE-RESORPTION STUDY IN-VITRO - HUMAN OSTEOCLAST-LIKE CELLS FROM GIANT-CELL TUMORS OF BONE 66
Bone cells and the mechanisms of bone remodelling 66
the effect of microgravity on osteoblast metabolism 66
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 66
Apparent cure of a newborn with malignant osteopetrosis using prednisone therapy 66
OSTEOBLAST-OSTEOCLAST RELATIONSHIPS IN BONE-RESORPTION - OSTEOBLASTS ENHANCE OSTEOCLAST ACTIVITY IN A SERUM-FREE COCULTURE SYSTEM 65
Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. 65
Imbalance of osteoclastogenesis-regulating factors in celiac disease 65
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 65
Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling 65
CALCITONIN INCREASES CYTOSOLIC-FREE CALCIUM-CONCENTRATION VIA CAPACITATIVE CALCIUM INFLUX 65
beta 1 Integrin antisense oligodeoxynucleotides: utility in controlling osteoclast function 64
A novel calcium sensor stimulating inositol phosphate formation and [Ca2+](i) signaling expressed by GCT23 osteoclast-like cells 64
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 64
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 64
Tartronates: A new generation of drugs affecting bone metabolism 64
Decreased c-Src expression enhances osteoblast differentiation and bone formation 64
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 63
CALCIUM RELEASE-ACTIVATED CALCIUM INFLUX IN CULTURED HUMAN MESANGIAL CELLS 63
EFFECTS OF CALCIUM-PHOSPHATE-BASED MATERIALS ON PROLIFERATION AND ALKALINE-PHOSPHATASE ACTIVITY OF NEWBORN RAT PERIOSTEAL CELLS-INVITRO 63
Immediate cell signal induced by laminin in rat Sertoli cells 63
EFFECT OF VITAMIN-A ON BONE-RESORPTION - EVIDENCE FOR DIRECT STIMULATION OF ISOLATED CHICKEN OSTEOCLASTS BY RETINOL AND RETINOIC ACID 63
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 62
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene 62
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 62
Recent advances in mesenchymal stem cell immunomodulation. The role of microvesicles 61
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations 61
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 61
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 61
REGULATION OF CELLULAR FUNCTIONS BY EXTRACELLULAR-MATRIX 61
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 61
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 61
Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. 60
ADHESION PROPERTIES AND INTEGRIN EXPRESSION OF CULTURED HUMAN OSTEOCLAST-LIKE CELLS 60
Chronic inflammatory intestinal diseases and bone loss 60
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 60
AUTORADIOGRAPHIC DEMONSTRATION OF INVITRO FUSION OF BLOOD MONOCYTES WITH OSTEOCLASTS 59
Mechanisms of osteoclast-dependent bone formation 59
Totale 7.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019493 0 0 0 0 0 0 0 0 0 0 30 463
2019/20201.600 362 13 183 7 7 274 319 10 196 26 4 199
2020/20211.726 44 222 1 195 194 89 198 15 206 93 364 105
2021/20221.434 89 135 344 91 62 39 33 83 103 26 76 353
2022/20233.638 283 186 68 367 349 415 5 279 1.498 14 116 58
2023/2024803 125 52 66 160 61 266 17 21 5 30 0 0
Totale 11.884